Jeffrey S. Farrow, See Remarks at Tarsus Pharmaceuticals, Inc. (TARS), sold 6,430 shares at $69.42 ($440K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Open-market sale of $440k TARS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.42 | 2,111 | $147K | 33.3% |
| 2 | $68.71 | 2,133 | $147K | 33.3% |
| 3 | $67.00 | 2,186 | $146K | 33.3% |
| Total | $68.36 avg | 6,430 | $440K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $357K | — | Filing → |
| TARS | SELL | 2024-06-20 | $574K | — | Filing → |
| GBT | SELL | 2022-09-06 | $2.1M | — | Filing → |